The Decline Theory in neurology states that the pathophysiology of neurological diseases results in an overall decrease in brain activity. It is an alternative to the Excitotoxicity Theory, which suggests that increased neuron activity is a primary cause of neurodegenerative diseases. The Decline Theory suggests that the decrease in brain activity is due to decreased synaptic communication between neurons and a decreased release of neurotransmitters. There are three main components of the Decline Theory. First, neuronal networks and connections become weakened as the interactions between neurons slow down. This results in less information being exchanged between neurons leading to a decrease in brain activity. Secondly, decreased release of neurotransmitters can occur due to a decrease in neurotransmitter production, or because of neuronal dysfunction. Finally, the degeneration of axons can lead to disruption and damage to neural networks resulting in a decrease of brain activity. The Decline Theory has been proposed in neurological diseases such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. It is often suggested to be a more comprehensive explanation for the pathogenesis of these diseases than the Excitotoxicity Theory, as it takes into account both the decreased activity of neurons and the decline in the networks that these neurons are connected to. In addition, the Decline Theory suggests that therapies for neurological diseases should focus on both restoring the function of existing neurons and connecting them effectively, as well as forming new, strong neuronal networks. This differs from the Excitotoxicity Theory, which suggests therapies should focus solely on restoring excitatory activity. A better understanding of the molecular pathways and mechanisms of the Decline Theory could lead to improved treatments and interventions for neurological diseases.
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : In silico in vitro and in vivo study of geraniol role in Alzheimer's disease
Bhuvanesh Baniya, Mohanlal Sukhadia University, India
Title : Prince transform: a wave-mechanical framework for real-time EEG analysis and early seizure prediction using chirp and drift detection
Mustafa A Khan, Sevaro Health Inc., United States
Title : Gut-brain axis in autism spectrum disorder: MicroRNAs as a critical mediator of pathogenesis
Rahem Rahmati, Shahrekord University of Medical Sciences, Iran (Islamic Republic of)